118
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Prognostic Value and Biological Functions of HFM1 in Breast Cancer

, , , , , , , , & show all
Pages 147-166 | Received 06 Feb 2023, Accepted 21 Mar 2023, Published online: 05 Apr 2023

References

  • Ferlay J , Steliarova-FoucherE , Lortet-TieulentJet al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur. J. Cancer49(6), 1374–1403 (2013).
  • Zahmatkesh B , KeramatA , AlaviNet al. Breast cancer trend in Iran from 2000 to 2009 and prediction till 2020 using a trend analysis method. Asian Pac. J. Cancer Prev.17(3), 1493–1498 (2016).
  • Boggs DA , PalmerJR , WiseLAet al. Fruit and vegetable intake in relation to risk of breast cancer in the Black Women’s Health Study. Am. J. Epidemiol.172(11), 1268–1279 (2010).
  • Chandran U , MccannSE , ZirpoliGet al. Intake of energy-dense foods, fast foods, sugary drinks, and breast cancer risk in African American and European American women. Nutr. Cancer66(7), 1187–1199 (2014).
  • Palmer JR , BoggsDA , WiseLA , Adams-CampbellLL , RosenbergL. Individual and neighborhood socioeconomic status in relation to breast cancer incidence in African American women. Am. J. Epidemiol.176(12), 1141–1146 (2012).
  • Harshman LC , WangX , NakabayashiMet al. Statin use at the time of initiation of androgen deprivation therapy and time to progression in patients with hormone-sensitive prostate cancer. JAMA Oncol.1(4), 495–504 (2015).
  • Tian N , GoovaertsP , ZhanFB , ChowTE , WilsonJG. Identifying risk factors for disparities in breast cancer mortality among African-American and Hispanic women. Womens Health Issues22(3), e267–276 (2012).
  • Choi J , YoonYN , KimNet al. Predicting radiation resistance in breast cancer with expression status of phosphorylated S6K1. Sci. Rep.10(1), 641 (2020).
  • Speers C , ZhaoS , LiuM , BartelinkH , PierceLJ , FengFY. Development and validation of a novel radiosensitivity signature in human breast cancer. Clin. Cancer Res.21(16), 3667–3677 (2015).
  • Duru N , FanM , CandasDet al. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells. Clin. Cancer Res.18(24), 6634–6647 (2012).
  • Nik-Zainal S , DaviesH , StaafJet al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature534(7605), 47–54 (2016).
  • Moynahan ME , JasinM. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat. Rev. Mol. Cell Biol.11(3), 196–207 (2010).
  • Meijers-Heijboer H , VanDen Ouweland A , KlijnJet al. Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet.31(1), 55–59 (2002).
  • Easton DF , PooleyKA , DunningAMet al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature447(7148), 1087–1093 (2007).
  • Michailidou K , HallP , Gonzalez-NeiraAet al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat. Genet.45(4), 353–361361e351–352 (2013).
  • Wopereis S , WalterLO , VieiraDSCet al. Evaluation of ER, PR and HER2 markers by flow cytometry for breast cancer diagnosis and prognosis. Clin. Chim. Acta523, 504–512 (2021).
  • Chang HY , LiMH , HuangTCet al. Quantitative proteomics reveals middle infrared radiation-interfered networks in breast cancer cells. J. Proteome Res.14(2), 1250–1262 (2015).
  • Cancer Genome Atlas N . Comprehensive molecular portraits of human breast tumours. Nature490(7418), 61–70 (2012).
  • Guiraldelli MF , EysterC , WilkersonJL , DresserME , PezzaRJ. Mouse HFM1/Mer3 is required for crossover formation and complete synapsis of homologous chromosomes during meiosis. PLoS Genet.9(3), e1003383 (2013).
  • Wang H , ZhongC , YangRet al. HFM1 participates in Golgi-associated spindle assembly and division in mouse oocyte meiosis. Cell Death Dis.11(6), 490 (2020).
  • Kowalczykowski SC . Saccharomyces cerevisiae Mer3 helicase stimulates 3′–5′ heteroduplex extension by Rad51: implications for crossover control in meiotic recombination. Cell117, 47–56 (2004).
  • Pu D , WangC , CaoJet al. Association analysis between HFM1 variation and primary ovarian insufficiency in Chinese women. Clin. Genet.89(5), 597–602 (2016).
  • Qin Y , JiaoX , SimpsonJL , ChenZJ. Genetics of primary ovarian insufficiency: new developments and opportunities. Hum. Reprod. Update21(6), 787–808 (2015).
  • Wang J . Mutations in HFM1 in recessive primary ovarian insufficiency. N. Engl. J. Med.370(10), 972–974 (2014).
  • Yang F , XieHY , YangLFet al. Stabilization of MORC2 by estrogen and antiestrogens through GPER1-PRKACA-CMA pathway contributes to estrogen-induced proliferation and endocrine resistance of breast cancer cells. Autophagy16(6), 1061–1076 (2020).
  • Kulkoyluoglu-Cotul E , ArcaA , Madak-ErdoganZ. Crosstalk between estrogen signaling and breast cancer metabolism. Trends Endocrinol. Metab.30(1), 25–38 (2019).
  • Siersbæk R , KumarS , CarrollJS. Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer. Genes Dev.32(17-18), 1141–1154 (2018).
  • Waterhouse A , BertoniM , BienertSet al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res.46(W1), W296–W303 (2018).
  • Varadi M , AnyangoS , DeshpandeMet al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res.50(D1), D439–D444 (2022).
  • Jumper J , EvansR , PritzelAet al. Highly accurate protein structure prediction with AlphaFold. Nature596(7873), 583–589 (2021).
  • Wu Q , GouY , WangQet al. Downregulation of RPL6 by siRNA inhibits proliferation and cell cycle progression of human gastric cancer cell lines. PLOS ONE6(10), e26401 (2011).
  • Li T , FanJ , WangBet al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res.77(21), e108–e110 (2017).
  • Li B , SeversonE , PignonJCet al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol.17(1), 174 (2016).
  • Tang Z , LiC , KangB , GaoG , LiC , ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res.45(W1), W98–W102 (2017).
  • Li C , TangZ , ZhangW , YeZ , LiuF. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res.49(W1), W242–W246 (2021).
  • Chandrashekar DS , BashelB , BalasubramanyaSaHet al. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia19(8), 649–658 (2017).
  • Chandrashekar DS , KarthikeyanSK , KorlaPKet al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia25, 18–27 (2022).
  • UALCAN . HFM1 promoter methylation profile in breast invasive carcinoma. http://ualcan.path.uab.edu/cgi-bin/TCGA-methyl-Result.pl?genenam=HFM1&ctype=BRCA
  • Shi J , ChenL , ChenY , LuY , ChenX , YangZ. Aldo-keto reductase family 1 member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma. J. Cancer10(20), 4892–4901 (2019).
  • Gao J , AksoyBA , DogrusozUet al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal.6(269), pl1 (2013).
  • Benonisson H , AltintasI , SluijterMet al. CD3-bispecific antibody therapy turns solid tumors into inflammatory sites but does not install protective memory. Mol. Cancer Ther.18(2), 312–322 (2019).
  • Maclean A , BunniE , MakrydimaSet al. Fallopian tube epithelial cells express androgen receptor and have a distinct hormonal responsiveness when compared with endometrial epithelium. Hum. Reprod.35(9), 2097–2106 (2020).
  • Dogan S , VasudevarajaV , XuBet al. DNA methylation-based classification of sinonasal undifferentiated carcinoma. Mod. Pathol.32(10), 1447–1459 (2019).
  • Xie P , ZhangM , HeSet al. The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis. Nat. Commun.5, 3733 (2014).
  • Uhlen M , OksvoldP , FagerbergLet al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol.28(12), 1248–1250 (2010).
  • The Human Protein Atlas . TCGA survival. https://www.proteinatlas.org/about/assays+annotation#tcga_survival
  • Zhang J , HouS , GuJet al. S100A4 promotes colon inflammation and colitis-associated colon tumorigenesis. Oncoimmunology7(8), e1461301 (2018).
  • Vasaikar SV , StraubP , WangJ , ZhangB. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res.46(D1), D956–D963 (2018).
  • Szklarczyk D , GableAL , NastouKCet al. The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res.49(D1), D605–D612 (2021).
  • Belinky F , NativN , StelzerGet al. PathCards: multi-source consolidation of human biological pathways. Database (Oxford)2015, bav006 (2015).
  • Yang M , QiuY , YangY , WangW. An integrated analysis of the identified PRPF19 as an onco-immunological biomarker encompassing the tumor microenvironment, disease progression, and prognoses in hepatocellular carcinoma. Front. Cell Dev. Biol.10, 840010 (2022).
  • Ge J , LiuH , QianDet al. Genetic variants of genes in the NER pathway associated with risk of breast cancer: a large-scale analysis of 14 published GWAS datasets in the DRIVE study. Int. J. Cancer145(5), 1270–1279 (2019).
  • Yang H , MaL , WangYet al. Activation of ClC-3 chloride channel by 17beta-estradiol relies on the estrogen receptor alpha expression in breast cancer. J. Cell. Physiol.233(2), 1071–1081 (2018).
  • Yang P , FengX , LiJet al. Ionizing radiation downregulates estradiol synthesis via endoplasmic reticulum stress and inhibits the proliferation of estrogen receptor-positive breast cancer cells. Cell Death Dis.12(11), 1029 (2021).
  • Tanaka K , MiyamotoN , Shouguchi-MiyataJ , IkedaJE. HFM1, the human homologue of yeast Mer3, encodes a putative DNA helicase expressed specifically in germ-line cells. DNA Seq.17(3), 242–246 (2006).
  • Schorr S , NguyenD , HassdenteufelSet al. Identification of signal peptide features for substrate specificity in human Sec62/Sec63-dependent ER protein import. FEBS J.287(21), 4612–4640 (2020).
  • Hausmann S , GeiserJ , VadasO , DucretV , PerronK , ValentiniM. Auxiliary domains of the HrpB bacterial DExH-box helicase shape its RNA preferences. RNA Biol.17(5), 637–650 (2020).
  • Fleischer T , TekpliX , MathelierAet al. DNA methylation at enhancers identifies distinct breast cancer lineages. Nat. Commun.8(1), 1379 (2017).
  • Sui S , AnX , XuCet al. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Theranostics10(26), 11938–11949 (2020).
  • Wang S , ZhangQ , YuC , CaoY , ZuoY , YangL. Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer. Brief. Bioinform.22(2), 2020–2031 (2021).
  • Stenstrom J , HedenfalkI , HagerlingC. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression. Breast Cancer Res.23(1), 27 (2021).
  • Cesari E , LoiarroM , NaroCet al. Combinatorial control of Spo11 alternative splicing by modulation of RNA polymerase II dynamics and splicing factor recruitment during meiosis. Cell Death Dis.11(4), 240 (2020).
  • Strong ER , SchimentiJC. Evidence implicating CCNB1IP1, a RING domain-containing protein required for meiotic crossing over in mice, as an E3 SUMO ligase. Genes (Basel)1(3), 440–451 (2010).
  • Abdullah MF , HoffmannER , CottonVE , BortsRH. A role for the MutL homologue MLH2 in controlling heteroduplex formation and in regulating between two different crossover pathways in budding yeast. Cytogenet. Genome Res.107(3–4), 180–190 (2004).
  • Milano CR , HollowayJK , ZhangYet al. Mutation of the ATPase domain of MutS Homolog-5 (MSH5) reveals a requirement for a functional MutSgamma complex for all crossovers in mammalian meiosis. G3 (Bethesda)9(6), 1839–1850 (2019).
  • Uanschou C , RonceretA , Von HarderMet al. Sufficient amounts of functional HOP2/MND1 complex promote interhomolog DNA repair but are dispensable for intersister DNA repair during meiosis in Arabidopsis. Plant Cell25(12), 4924–4940 (2013).
  • Gu W , DongN , WangP , ShiC , YangJ , WangJ. Tamoxifen resistance and metastasis of human breast cancer cells were mediated by the membrane-associated estrogen receptor ER-alpha36 signaling in vitro. Cell Biol. Toxicol.33(2), 183–195 (2017).
  • Davies C , PanH , GodwinJet al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet381(9869), 805–816 (2013).
  • Tian Y , JiangWL , WangWX , MaoGJ , LiY , LiCY. NAD(P)H-triggered probe for dual-modal imaging during energy metabolism and novel strategy of enhanced photothermal therapy in tumor. Biomaterials271, 120736 (2021).
  • Jones CL , InguvaA , JordanCT. Targeting energy metabolism in cancer stem cells: progress and challenges in leukemia and solid tumors. Cell Stem Cell28(3), 378–393 (2021).
  • Pavlova NN , ThompsonCB. The emerging hallmarks of cancer metabolism. Cell Metab.23(1), 27–47 (2016).
  • Boroughs LK , DeberardinisRJ. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol.17(4), 351–359 (2015).
  • Li X , WenesM , RomeroP , HuangSC , FendtSM , HoPC. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy. Nat. Rev. Clin. Oncol.16(7), 425–441 (2019).
  • Basu A , RamamoorthiG , JiaYet al. Immunotherapy in breast cancer: current status and future directions. Adv. Cancer Res.143, 295–349 (2019).
  • Barzaman K , Moradi-KalbolandiS , HosseinzadehAet al. Breast cancer immunotherapy: current and novel approaches. Int. Immunopharmacol.98, 107886 (2021).
  • Cao Y , ChenC , TaoY , LinW , WangP. Immunotherapy for triple-negative breast cancer. Pharmaceutics13(12), 2003 (2021).
  • Jen J , WangYC. Zinc finger proteins in cancer progression. J. Biomed. Sci.23(1), 53 (2016).
  • Yang L , WangH , KornblauSMet al. Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating cyclin D2 expression in multiple myeloma. Oncogene30(11), 1329–1340 (2011).
  • Kowalczyk AE , KrazinskiBE , GodlewskiJet al. Altered expression of the PLAGL1 (ZAC1/LOT1) gene in colorectal cancer: correlations to the clinicopathological parameters. Int. J. Oncol.47(3), 951–962 (2015).
  • Singh JK , Van AttikumH. DNA double-strand break repair: putting zinc fingers on the sore spot. Semin. Cell Dev. Biol.113, 65–74 (2021).
  • Cassandri M , SmirnovA , NovelliFet al. Zinc-finger proteins in health and disease. Cell Death Discov.3, 17071 (2017).
  • Ray Chaudhuri A , NussenzweigA. The multifaceted roles of PARP1 in DNA repair and chromatin remodelling. Nat. Rev. Mol. Cell Biol.18(10), 610–621 (2017).
  • van Beek L , McClayE , PatelS , SchimplM , SpagnoloL , de OliveiraTM. PARP power: a structural perspective on PARP1, PARP2, and PARP3 in DNA damage repair and nucleosome remodelling. Int. J. Mol. Sci.22(10), 5112 (2021).
  • Moison C , ChagraouiJ , CaronMCet al. Zinc finger protein E4F1 cooperates with PARP-1 and BRG1 to promote DNA double-strand break repair. Proc. Natl Acad. Sci. USA118(11), e2019408118 (2021).
  • Wang J , YangJ , LiD , LiJ. Technologies for targeting DNA methylation modifications: basic mechanism and potential application in cancer. Biochim. Biophys. Acta Rev. Cancer1875(1), 188454 (2021).
  • Skvortsova K , StirzakerC , TaberlayP. The DNA methylation landscape in cancer. Essays Biochem.63(6), 797–811 (2019).
  • Li Q , EngebrechtJ. BRCA1 and BRCA2 tumor suppressor function in meiosis. Front. Cell Dev. Biol.9, 668309 (2021).
  • Mimitou EP , KeeneyS. S1-seq assay for mapping processed DNA ends. Methods Enzymol.601, 309–330 (2018).
  • Brown SD , AudoynaudC , LorenzA. Intragenic meiotic recombination in Schizosaccharomyces pombe is sensitive to environmental temperature changes. Chromosome Res.28(2), 195–207 (2020).
  • Nakagawa T , KolodnerRD. Saccharomyces cerevisiae Mer3 is a DNA helicase involved in meiotic crossing over. Mol. Cell. Biol.22(10), 3281–3291 (2002).
  • Dubois E , DeMuyt A , SoyerJLet al. Building bridges to move recombination complexes. Proc. Natl Acad. Sci. USA116(25), 12400–12409 (2019).
  • Rner GVB . Crossover/noncrossover differentiation, synaptonemal complex formation, and regulatory surveillance at the leptotene/zygotene transition of meiosis. Cell117, 29–45 (2004).
  • Jessop L , RockmillB , RoederGS , LichtenM. Meiotic chromosome synapsis-promoting proteins antagonize the anti-crossover activity of SGS1. PLoS Genet.2(9), e155 (2006).
  • De Vries FA , DeBoer E , VanDen Bosch Met al. Mouse Sycp1 functions in synaptonemal complex assembly, meiotic recombination, and XY body formation. Genes Dev.19(11), 1376–1389 (2005).
  • Page SL , HawleyRS. The genetics and molecular biology of the synaptonemal complex. Annu. Rev. Cell Dev. Biol.20, 525–558 (2004).
  • Chen C , ZhangW , TimofejevaL , GerardinY , MaH. The ArabidopsisROCK-N-ROLLERS gene encodes a homolog of the yeast ATP-dependent DNA helicase MER3 and is required for normal meiotic crossover formation. Plant J.43(3), 321–334 (2005).
  • Sugawara H , IwabataK , KoshiyamaAet al. Coprinus cinereus Mer3 is required for synaptonemal complex formation during meiosis. Chromosoma118(1), 127–139 (2009).
  • De Los Santos T , HunterN , LeeC , LarkinB , LoidlJ , HollingsworthNM. The Mus81/Mms4 endonuclease acts independently of double-Holliday junction resolution to promote a distinct subset of crossovers during meiosis in budding yeast. Genetics164(1), 81–94 (2003).
  • Chen X , SuhandynataRT , SandhuRet al. Phosphorylation of the synaptonemal complex protein Zip1 regulates the crossover/noncrossover decision during yeast meiosis. PLoS Biol.13(12), e1002329 (2015).
  • Bian L , MengY , ZhangMet al. ATM expression is elevated in established radiation-resistant breast cancer cells and improves DNA repair efficiency. Int. J. Biol. Sci.16(7), 1096–1106 (2020).
  • Bai Y , WangW , LiSet al. C1QBP promotes homologous recombination by stabilizing MRE11 and controlling the assembly and activation of MRE11/RAD50/NBS1 complex. Mol. Cell75(6), 1299–1314e1296 (2019).
  • Engelman JA , LuoJ , CantleyLC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet.7(8), 606–619 (2006).
  • Verret B , CortesJ , BachelotT , AndreF , ArnedosM. Efficacy of PI3K inhibitors in advanced breast cancer. Ann. Oncol.30, x12–x20 (2019).
  • Miller TW , HennessyBT , Gonzalez-AnguloAMet al. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer. J. Clin. Invest.120(7), 2406–2413 (2010).
  • Lu PW , LiL , WangF , GuYT. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway. J. Cell. Physiol.234(2), 1904–1912 (2019).
  • Xu Z , ZhengX , XiaXet al. 17beta-estradiol at low concentrations attenuates the efficacy of tamoxifen in breast cancer therapy. Environ. Pollut.255(Pt 2), 113228 (2019).
  • Ros S , WrightAJ , D’santosPet al. Metabolic imaging detects resistance to PI3Kα inhibition mediated by persistent FOXM1 Expression in ER+ breast cancer. Cancer Cell38(4), 516–533e519 (2020).
  • Saha T , MakarS , SwethaR , GuttiG , SinghSK. Estrogen signaling: an emanating therapeutic target for breast cancer treatment. Eur. J. Med. Chem.177, 116–143 (2019).
  • Mayayo-Peralta I , PrekovicS , ZwartW. Estrogen receptor on the move: cistromic plasticity and its implications in breast cancer. Mol. Aspects Med.78, 100939 (2021).
  • Trabert B , ShermanME , KannanN , StanczykFZ. Progesterone and breast cancer. Endocr. Rev.41(2), 320–344 (2020).
  • Figee M , MaybergH. The future of personalized brain stimulation. Nat. Med.27(2), 196–197 (2021).
  • Bradley R , BraybrookeJ , GrayRet al. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Lancet Oncol.23(3), 382–392 (2022).
  • Bartlett JMS , SgroiDC , TreunerKet al. Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen – To Offer More? (aTTom) trial. Ann. Oncol.30(11), 1776–1783 (2019).
  • Wang J , XieS , YangJet al. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy. J. Hematol. Oncol.12(1), 81 (2019).
  • Choi HJ , JooHS , WonHYet al. Role of RBP2-induced ER and IGF1R–ErbB signaling in tamoxifen resistance in breast cancer. J. Natl Cancer Inst.110(4),doi:10.1093/jnci/djx207 (2018).
  • Yu TJ , MaD , LiuYYet al. Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers. Mol. Ther.29(7), 2350–2365 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.